Case Study: Top Pharmaceutical Company achieves faster real-world evidence insights with Saama Technologies

Top pharmaceutical company maximizes Real World Evidence investments

A top pharmaceutical company was struggling to leverage its Real World Evidence (RWE) investments. The company faced significant challenges in accessing, querying, and analyzing its Real World Data (RWD), a process that was manual and could take expert programmers up to three months to complete. They required a solution to generate market access insights more quickly and with less effort.

Saama Technologies implemented a customized solution using its Treatment Pathways Analytics for the company's Oncology franchise. This provided a user-friendly interface and a consolidated view of patient data, enabling the analysis of RWE and delivery of insights in less than three months. The Saama solution empowered various teams to discover treatment trends and make more informed, timely decisions, leading to its rapid adoption and expansion to another franchise.